# LLM call: summary

- Turn: 13
- Sequence: 7
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 899
- Completion tokens: 585
- Total tokens: 1484
- Cost (USD): 0.000207

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1711: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
By late 2030 the US cut off European licences for the leading American model, forcing hospitals and services to paper and queues. Brussels imposed an emergency fallback to older EU-hosted Observatory-vetted models with manual sign-off and kill-switches, avoiding cascade at cost of slower operations, under continued tiered-access rationing and failed pleas for humanitarian licences.

In winter-spring 2031 uninsured clinics reverted to paper after ransomware probes; patching crews and conditional state cover reconnected about half, the rest refused as unsafe/unfunded. A circulating genome model claiming a viable human-infecting design prompted enhanced pathogen reporting and triage stocks, straining labs. Diplomacy in Washington and Beijing yielded no licences.

In Feb-June 2032 a model-built ransomware sweep hit municipal administrations, two hospital networks and shared appointment/billing software from the Rhine to Po valley. ENISA triage — isolate, fallback to separated systems, restore from backups — prevented collapse of grid or emergency care, but queues doubled and defenders lagged for weeks with attribution open. Reconnected clinics under state cover stayed open; paper wards did not.

In March investigation revealed avoidable harms — wrong doses, missed referrals, delayed oncology — from paper transcription and substitute referral software; joint audit confirmed both unsafe, fuelling blame over the fallback. Meanwhile tailored therapies advanced elsewhere but remained unavailable in Europe except delayed compassionate-use cases. By June ministers again claimed no cascade, but endurance credit was exhausted and blame settled on the European fallback itself.

CURRENT NARRATIVE:
### Holding the line
Through autumn 2022 the emergency triage operation became the health system in much of southern and western Europe. Field teams moved from town hall to hospital, cutting infected networks apart, restarting appointment and billing software from clean backups, and leaving wards on separated domestic systems that required a clinician to sign every machine suggestion.

Where that discipline held, services stayed open in degraded form. Where it did not, they closed. The half of previously paper-reverted clinics that had accepted conditional cover and the isolated build kept seeing patients through the new automated assault. Queues lengthened again, operations were postponed, but emergency departments did not go dark.

Defenders were openly behind. The intrusion tooling had been assembled with machine help, moved fast across a shared dependency, and left administrators unsure for weeks how far it had spread. Attribution remained unresolved in December.

### The audit and the cures
The joint audit with national regulators published every Friday. Its message hardened: transcription on paper wards and errors in the substitute referral software had both contributed to wrong doses, missed referrals and delayed cancer care. No side was vindicated. Families continued to appear on television; directors who had refused state funds cited the reports as proof the substitutes were unsafe, while Brussels cited them as proof paper killed.

At the same time, reports of tailored treatments in remission abroad became routine viewing. Referrals through compassionate-use channels were still refused or answered months late. Travel agencies and foreign clinics began advertising oncology packages openly in southern member states, and a non-EU hospital group was said to be sounding out clinicians about referring selected cases abroad. Nothing was confirmed, but waiting rooms talked of little else.

By December export paperwork tightened once more. American licences remained tiered and scarce, and officials privately conceded humanitarian exemptions were stalled. Ministers repeated that nothing essential had cascaded. It was true, and it no longer persuaded.
```

## Raw response

```
By late 2030 the US cut off European licences for the leading American model, forcing hospitals and services to paper and queues. Brussels imposed an emergency fallback to older EU-hosted Observatory-vetted models with manual sign-off and kill-switches, avoiding cascade at cost of slower operations, under continued tiered-access rationing and failed pleas for humanitarian licences.

In winter-spring 2031 uninsured clinics reverted to paper after ransomware probes; patching crews and conditional state cover reconnected about half, the rest refused as unsafe/unfunded. A circulating genome model claiming a viable human-infecting design prompted enhanced pathogen reporting and triage stocks, straining labs. Diplomacy in Washington and Beijing yielded no licences.

In Feb-June 2032 a model-built ransomware sweep hit municipal administrations, two hospital networks and shared appointment/billing software from the Rhine to Po valley. ENISA triage — isolate, fallback to separated systems, restore from backups — prevented collapse of grid or emergency care, but queues doubled and defenders lagged for weeks with attribution open. Reconnected clinics under state cover stayed open; paper wards did not.

In March investigation revealed avoidable harms — wrong doses, missed referrals, delayed oncology — from paper transcription and substitute referral software; joint audit confirmed both unsafe, fuelling blame over the fallback. Meanwhile tailored therapies advanced elsewhere but remained unavailable in Europe except delayed compassionate-use cases. By June ministers again claimed no cascade, but endurance credit was exhausted and blame settled on the European fallback itself.

Through autumn 2032 triage became the system: separated domestic systems with clinician sign-off kept emergency care open in degraded form where discipline held, queues lengthened and operations postponed, defenders openly behind with December attribution still unresolved. Weekly audits hardened that both paper and substitutes harmed patients, used by both sides for blame. Remissions abroad became routine viewing while compassionate-use stayed refused/late, fuelling open oncology-package advertising and reported foreign recruitment of clinicians. US licences stayed tiered and scarce with humanitarian exemptions stalled and export paperwork tightened; ministers' true claim of no cascade no longer persuaded.
```
